EDIT

Editas Medicine, Inc.

Insider trading activity for Editas Medicine, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

-$89.1K

net selling

Bought(0 · 0 insiders): $0
Sold(5 · 3 insiders): $89.1K

Past 6 months

-$148.8K

net selling

Bought(0 · 0 insiders): $0
Sold(10 · 3 insiders): $148.8K

Past 12 months

-$176.7K

net selling

Bought(0 · 0 insiders): $0
Sold(16 · 3 insiders): $176.7K

Transaction history

The 41 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Nov 11	Burkly Linda	EVP, Chief Scientific…	SSELL◷	7,814	$2.42	$18.9K	-10.0%	Open the original filing on SEC.gov
Nov 11	O'Neill Gilmore Neil	CEO	SSELL◷	21,164	$2.42	$51.1K	-7.4%	Open the original filing on SEC.gov
Nov 5	O'Neill Gilmore Neil	CEO	AGRANT	43,567	—	—	+17.9%	Open the original filing on SEC.gov
Nov 5	Burkly Linda	EVP, Chief Scientific…	AGRANT	16,533	—	—	+26.8%	Open the original filing on SEC.gov
Sep 8	Ory Daniel Scott	EVP, Chief Medical…	AGRANT◆	950,000	—	—	—	Open the original filing on SEC.gov
Sep 3	Burkly Linda	EVP, Chief Scientific…	SSELL◷	709	$3.04	$2.2K	-1.1%	Open the original filing on SEC.gov
Sep 3	Parison Amy	SVP, Chief Financial…	SSELL◷	453	$3.04	$1.4K	-3.2%	Open the original filing on SEC.gov
Sep 3	O'Neill Gilmore Neil	CEO	SSELL◷	5,124	$3.04	$15.6K	-2.1%	Open the original filing on SEC.gov
Aug 6	Ellinor Patrick Thomas…	Director	AGRANT◆	103,400	—	—	—	Open the original filing on SEC.gov
Aug 3	Parison Amy	SVP, Chief Financial…	SSELL◷	678	$2.58	$1.7K	-4.5%	Open the original filing on SEC.gov
Jul 28	Burkly Linda	EVP, Chief Scientific…	SSELL◷	4,928	$2.67	$13.2K	-7.3%	Open the original filing on SEC.gov
Jun 17	Hopfield Jessica	Director	AGRANT◆	51,700	—	—	—	Open the original filing on SEC.gov
Jun 17	Hirsch Andrew	Director	AGRANT◆	51,700	—	—	—	Open the original filing on SEC.gov
Jun 17	Scadden David	Director	AGRANT◆	51,700	—	—	—	Open the original filing on SEC.gov
Jun 17	Levy Elliott M.	Director	AGRANT◆	51,700	—	—	—	Open the original filing on SEC.gov
Jun 17	Connaughton Bernadette	Director	AGRANT◆	51,700	—	—	—	Open the original filing on SEC.gov
Jun 3	Parison Amy	SVP, Chief Financial…	SSELL◷	464	$2.70	$1.3K	-3.0%	Open the original filing on SEC.gov
Jun 3	O'Neill Gilmore Neil	CEO	SSELL◷	15,380	$2.70	$41.5K	-5.8%	Open the original filing on SEC.gov
Jun 3	Burkly Linda	EVP, Chief Scientific…	SSELL◷	731	$2.70	$2K	-1.1%	Open the original filing on SEC.gov
Mar 12	O'Neill Gilmore Neil	CEO	AGRANT◷◆	1M	—	—	—	Open the original filing on SEC.gov
Mar 12	Parison Amy	SVP, Chief Financial…	AGRANT◷◆	292,856	—	—	—	Open the original filing on SEC.gov
Mar 12	Burkly Linda	EVP, Chief Scientific…	AGRANT◷◆	292,856	—	—	—	Open the original filing on SEC.gov
Mar 3	O'Neill Gilmore Neil	CEO	SSELL◷	5,394	$2.02	$10.9K	-2.0%	Open the original filing on SEC.gov
Mar 3	Parison Amy	SVP, Chief Financial…	SSELL◷	474	$2.02	$957	-3.0%	Open the original filing on SEC.gov
Mar 3	Burkly Linda	EVP, Chief Scientific…	SSELL◷	749	$2.02	$1.5K	-1.1%	Open the original filing on SEC.gov
Dec 3, 2025	O'Neill Gilmore Neil	CEO	SSELL◷	5,603	$2.15	$12.1K	-2.0%	Open the original filing on SEC.gov
Dec 3, 2025	Parison Amy	SVP, Chief Financial…	SSELL◷	461	$2.15	$993	-2.8%	Open the original filing on SEC.gov
Dec 3, 2025	Burkly Linda	EVP, Chief Scientific…	SSELL◷	713	$2.15	$1.5K	-1.0%	Open the original filing on SEC.gov
Sep 3, 2025	Parison Amy	SVP, Chief Financial…	SSELL◷	458	$2.60	$1.2K	-2.7%	Open the original filing on SEC.gov
Sep 3, 2025	O'Neill Gilmore Neil	CEO	SSELL◷	5,592	$2.60	$14.5K	-2.0%	Open the original filing on SEC.gov
Sep 3, 2025	Burkly Linda	EVP, Chief Scientific…	SSELL◷	710	$2.60	$1.8K	-1.0%	Open the original filing on SEC.gov
Aug 7, 2025	Parison Amy	SVP, Chief Financial…	SSELL◷	679	$2.58	$1.8K	-3.9%	Open the original filing on SEC.gov
Jul 31, 2025	Burkly Linda	EVP, Chief Scientific…	SSELL◷	5,121	$2.49	$12.8K	-7.4%	Open the original filing on SEC.gov
Jun 6, 2025	Hopfield Jessica	Director	AGRANT◆	37,500	—	—	—	Open the original filing on SEC.gov
Jun 6, 2025	Scadden David	Director	AGRANT◆	37,500	—	—	—	Open the original filing on SEC.gov
Jun 6, 2025	Levy Elliott M.	Director	AGRANT◆	37,500	—	—	—	Open the original filing on SEC.gov
Jun 6, 2025	Hirsch Andrew	Director	AGRANT◆	37,500	—	—	—	Open the original filing on SEC.gov
Jun 6, 2025	Connaughton Bernadette	Director	AGRANT◆	37,500	—	—	—	Open the original filing on SEC.gov
Jun 3, 2025	Parison Amy	SVP, Chief Financial…	SSELL◷	446	$1.72	$769	-2.5%	Open the original filing on SEC.gov
Jun 3, 2025	O'Neill Gilmore Neil	CEO	SSELL◷	15,192	$1.72	$26.2K	-5.1%	Open the original filing on SEC.gov
Jun 3, 2025	Burkly Linda	EVP, Chief Scientific…	SSELL◷	726	$1.72	$1.3K	-1.0%	Open the original filing on SEC.gov

SSELL◷$18.9K

Burkly Linda · EVP, Chief Scienti…Nov 11

7,814 sh @ $2.42 · -10.0% own

SSELL◷$51.1K

O'Neill Gilmore Neil · CEONov 11

21,164 sh @ $2.42 · -7.4% own

AGRANT—

O'Neill Gilmore Neil · CEONov 5

43,567 sh · +17.9% own

AGRANT—

Burkly Linda · EVP, Chief Scienti…Nov 5

16,533 sh · +26.8% own

AGRANT◆—

Ory Daniel Scott · EVP, Chief Medical…Sep 8

950,000 sh

SSELL◷$2.2K

Burkly Linda · EVP, Chief Scienti…Sep 3

709 sh @ $3.04 · -1.1% own

SSELL◷$1.4K

Parison Amy · SVP, Chief Financi…Sep 3

453 sh @ $3.04 · -3.2% own

SSELL◷$15.6K

O'Neill Gilmore Neil · CEOSep 3

5,124 sh @ $3.04 · -2.1% own

AGRANT◆—

Ellinor Patrick Thomas… · DirectorAug 6

103,400 sh

SSELL◷$1.7K

Parison Amy · SVP, Chief Financi…Aug 3

678 sh @ $2.58 · -4.5% own

SSELL◷$13.2K

Burkly Linda · EVP, Chief Scienti…Jul 28

4,928 sh @ $2.67 · -7.3% own

AGRANT◆—

Hopfield Jessica · DirectorJun 17

51,700 sh

AGRANT◆—

Hirsch Andrew · DirectorJun 17

51,700 sh

AGRANT◆—

Scadden David · DirectorJun 17

51,700 sh

AGRANT◆—

Levy Elliott M. · DirectorJun 17

51,700 sh

AGRANT◆—

Connaughton Bernadette · DirectorJun 17

51,700 sh

SSELL◷$1.3K

Parison Amy · SVP, Chief Financi…Jun 3

464 sh @ $2.70 · -3.0% own

SSELL◷$41.5K

O'Neill Gilmore Neil · CEOJun 3

15,380 sh @ $2.70 · -5.8% own

SSELL◷$2K

Burkly Linda · EVP, Chief Scienti…Jun 3

731 sh @ $2.70 · -1.1% own

AGRANT◷◆—

O'Neill Gilmore Neil · CEOMar 12

1M sh

AGRANT◷◆—

Parison Amy · SVP, Chief Financi…Mar 12

292,856 sh

AGRANT◷◆—

Burkly Linda · EVP, Chief Scienti…Mar 12

292,856 sh

SSELL◷$10.9K

O'Neill Gilmore Neil · CEOMar 3

5,394 sh @ $2.02 · -2.0% own

SSELL◷$957

Parison Amy · SVP, Chief Financi…Mar 3

474 sh @ $2.02 · -3.0% own

SSELL◷$1.5K

Burkly Linda · EVP, Chief Scienti…Mar 3

749 sh @ $2.02 · -1.1% own

SSELL◷$12.1K

O'Neill Gilmore Neil · CEODec 3, 2025

5,603 sh @ $2.15 · -2.0% own

SSELL◷$993

Parison Amy · SVP, Chief Financi…Dec 3, 2025

461 sh @ $2.15 · -2.8% own

SSELL◷$1.5K

Burkly Linda · EVP, Chief Scienti…Dec 3, 2025

713 sh @ $2.15 · -1.0% own

SSELL◷$1.2K

Parison Amy · SVP, Chief Financi…Sep 3, 2025

458 sh @ $2.60 · -2.7% own

SSELL◷$14.5K

O'Neill Gilmore Neil · CEOSep 3, 2025

5,592 sh @ $2.60 · -2.0% own

SSELL◷$1.8K

Burkly Linda · EVP, Chief Scienti…Sep 3, 2025

710 sh @ $2.60 · -1.0% own

SSELL◷$1.8K

Parison Amy · SVP, Chief Financi…Aug 7, 2025

679 sh @ $2.58 · -3.9% own

SSELL◷$12.8K

Burkly Linda · EVP, Chief Scienti…Jul 31, 2025

5,121 sh @ $2.49 · -7.4% own

AGRANT◆—

Hopfield Jessica · DirectorJun 6, 2025

37,500 sh

AGRANT◆—

Scadden David · DirectorJun 6, 2025

37,500 sh

AGRANT◆—

Levy Elliott M. · DirectorJun 6, 2025

37,500 sh

AGRANT◆—

Hirsch Andrew · DirectorJun 6, 2025

37,500 sh

AGRANT◆—

Connaughton Bernadette · DirectorJun 6, 2025

37,500 sh

SSELL◷$769

Parison Amy · SVP, Chief Financi…Jun 3, 2025

446 sh @ $1.72 · -2.5% own

SSELL◷$26.2K

O'Neill Gilmore Neil · CEOJun 3, 2025

15,192 sh @ $1.72 · -5.1% own

SSELL◷$1.3K

Burkly Linda · EVP, Chief Scienti…Jun 3, 2025

726 sh @ $1.72 · -1.0% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 41 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →